CHPF Antikörper (N-Term)
Kurzübersicht für CHPF Antikörper (N-Term) (ABIN635153)
Target
Alle CHPF Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- N-Term
-
Spezifität
- CHSY2 antibody was raised against the N terminal Of Chsy-2
-
Aufreinigung
- Affinity purified
-
Immunogen
- CHSY2 antibody was raised using the N terminal Of Chsy-2 corresponding to a region with amino acids PPLQQRRRGREPEGATGLPGAPAAEGEPEEEDGGAAGQRRDGRPGSSHNG
-
-
-
-
Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
CHSY2 Blocking Peptide, (ABIN5612880), is also available for use as a blocking control in assays to test for specificity of this CHSY2 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of CHSY-2 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- CHPF (Chondroitin Polymerizing Factor (CHPF))
-
Andere Bezeichnung
- CHSY2
-
Hintergrund
- CHSY-2 has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. CHSY-2 transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Specific activity of CHSY-2 is much reduced compared to CHSY1.CSS3 is a glycosyltransferase that has both glucuronyltransferase and N-acetylgalactosaminyltransferase activities.
-
Molekulargewicht
- 100 kDa (MW of target protein)
-
Pathways
- Glycosaminoglycan Metabolic Process, SARS-CoV-2 Protein Interaktom
Target
-